China Vacuum Blood Collection Industry Trends, Estimates and Forecasts Report, 2014-2017

The Report China Vacuum Blood Collection Industry Report, 2014-2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -


Albany, NY -- (SBWIRE) -- 06/04/2015 -- The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it into specimens prior to blood analysis.

View Full Report at

As a key integral part of the vacuum blood collection system, vacuum blood collection tubes get chiefly used for collection and preservation of blood specimens. In 2009-2013, the consumption of vacuum blood collection tubes in China presented a CAGR of 22.1%, and the figure in 2014 was estimated to reach 4.702 billion pcs, with the per capita use of 3.44 pcs/a.

Given the huge potentials of Chinese vacuum blood collection market, foreign giants represented by BD, Terumo and Sekisui Chemical have set up sole proprietorships or joint ventures in China, and occupied the high-end market in the country. At present, foreign brands account for only about 30% of the sales volume, but share up to 60% of the revenue.

Download Sample Copy of this Report at

Amonglocal Chinese companies -- Improve Medical, Kehua Bio-engineering, Weigao, Rich Science Industry, Liuyang Medical Instrument Factory, Gongdong Medical, etc., Improve Medical is the leader with higher annual capacity, namely 500 million blood collection tubes and 200 million blood collection needles. In 2014, Improve Medical achieved the revenue of RMB232 million from vacuum blood collection system with the sales volume of 496 million pcs.

Lured by the promising vacuum blood collection industry, Yuyue Medical, China Sun Pharmaceutical Machinery and other medical device manufacturers have tapped into the industry.

In 2012, Yuyue Medical invested additional RMB80 million in Suzhou Yuyue Medical for the capacity construction of vacuum blood collection tubes and Air purifiers. In 2013, it embarked on the R & D of vacuum blood collection tubes. In October 2012, China Sun Pharmaceutical Machinery pledged to lavish RMB154.3 million in building 10 production lines of vacuum blood collection tubes and blood collection needles; upon completion, it will be capable of producing 400 million germ-free glass vacuum blood collection tubes, 400 million sterile plastic vacuum blood collection tubes and 800 million blood collection needles annually.

Table of Content

1 Overview
1.1 Definition
1.2 Classification

2 Overview of Global Vacuum Blood Collection Industry
2.1 Development Course
2.2 Status Quo

3 Overview of China Vacuum Blood Collection Industry
3.1 Status Quo
3.2 Relevant Policies
3.3 Barriers to Entry
3.4 Competition Pattern
3.5 Import and Export
3.5.1 Import
3.5.2 Export

4 Major Chinese Enterprises
4.1Guangzhou Improve Medical Instruments
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin

About ( is the most comprehensive collection of market research reports, supporting clients' market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, has built a veritable reputation for fulfilling the most exacting market research needs.


Toll Free: 866-997-4948

Tel: +1-518-618-1030